Pomecins are antifungal ingredients. Initially pursued as pharmaceuticals, they have potential uses in crop protection, personal care and food preservation. However Evolva regards Pomecins as legacy products due to their synthetic method of production, which is not synergistic with our focus on fermentation. There are no current activities by Evolva or third parties around this product.


  • EV-077 is a more potent inhibitor of platelet function than aspirin

    EV-077 is one of our legacy pharma programs. In this study the platelet function of EV-077 is compare to aspirin. Out-licensed to Norway's Serodus ASA, EV-077 is being developed for diabetic nephropathy, a progressive kidney disease stemming from diabetes.

    Journal of Thrombosis & Haemostasis
  • EV-035: 2-pyridone-based topoisomerase inhibitors

    A presentation on EV-035 at the Superbugs and Superdrugs conference in 2012

More articles

Sign up to receive our
Press Releases!

Sign up